PAP SMEAR FINDINGS AMONG WOMEN SCREENED FOR CERVICAL CANCER AT THE NATIONAL OBSTETRIC FISTULA CENTRE, ABAKALIKI, SOUTH-EAST, NIGERIA BY Dr OKENWA SAMUEL.

Slides:



Advertisements
Similar presentations
Association of glycemic status with the types and severity of foot complications in leprosy patients Palash Chandra Banik MPhil in NCD Dept. of Community.
Advertisements

Cervical Cancer and Vaccines
FACTORS AFFECTING UPTAKE OF CERVICAL CANCER SCREENING AMONG WOMEN IN NAKASONGOLA DISTRICT, UGANDA AFENET Scientific Conference Authors: John Kamulegeya,
Periodic Woman Screening Sheet By Periodic Woman Screening Committee January 2010.
Cervical Cancer. Dr. Swapna Chaudhary M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
How to do cervical pap smear
Introduction Women experience distress and heightened anxiety in relation to further diagnostic evaluation of pre-cancerous cell changes of the cervix,
Barriers to Papanicolaou Screening among HIV-Infected Women: a cross sectional survey Arya Payan M.S., B.S. Touro University, Nevada University of Nevada.
ASHLYN SAVAGE, MD, MSCR ASSOCIATE PROFESSOR OBSTETRICS AND GYNECOLOGY MEDICAL UNIVERSITY OF SOUTH CAROLINA Managing Abnormal Pap Smears: Incorporating.
ACCP Evidence base: Implications for policy and practice R. Sankaranarayanan MD Head, Screening Group World Health Organization (WHO) International Agency.
Cervical Cancer: Molecular Impact of an Infectious Disease.
ANNE MURUGI1,2 1.Amref Health Africa 2.University of Nairobi
Impact of Side Effects of Antipsychotics on Attitude and Adherence to Treatment among Adult Psychiatric Outpatients at Mathari Hospital in Kenya Defense.
Benign and premalignant disease of the cervix
NIGERIA FIELD EPIDEMIOLOGY AND LABORATORY TRAINING PROGRAMME Risk Factors of Cervical Cancer and Prevalence of Precancerous Cervical Changes among Sexually.
AN AUDIT OF PAP SMEAR, COLPOSCOPY AND HISTOLOGY RESULTS FROM IN TUNGARU CENTRAL HOSPITAL (KIRIBATI)
Dr. George Papanicolaou
Reproductive health. Cancer Definition Cancer Definition The abnormal growth of cells without normal control of body. Types of Cancer  Malignant Cancer.
Social Economic Determinants of Cervical Cancer among Women Attending Referral Hospitals in Dar Es Salaam, Tanzania Karugira Rweyemamu 1,3, Janneth.
Bayesian Modelling for Clinical Decision Support: Cervical Cancer Screening1/31 University of Pittsburgh Medical Center (UPMC) Magee-Womens Hospital (MWH)
Cervical screening Tim Wright Sept 07. Introduction What who when What who when Benefits (evidence) Benefits (evidence) Cost Cost Does it fit wilson’s.
CERVICAL SCREENING WITH LUVIVA MACHINE FOR EARLY DETECTION OF CERVICAL DYSPLASIA: EXPERIENCE FROM EKITI STATE, NIGERIA Sunday O. Omoya, Abimbola M. Obimakinde.
Screening Tests for Brest & Cervical Cancer
Department of Community Medicine, LAUTECH Teaching Hospital, Ogbomoso
Screening for Cervical Cancer by Visual Inspection Techniques Dr Aruna Batra VMMC & SJH.
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
PATTERN OF GYNAECOLOGICAL MALIGNANCIES IN DELTA STATE UNIVERSITY TEACHING HOSPITAL,OGHARA:A 2 YEAR REVIEW. MOFON C EBEIGBE P.E ABEDI H.O DELSUTH.
Evaluation of Primary Versus Secondary Prevention of Cervical Cancer: an evidence based literature review Jennifer Vestle, PA-S, John Carter, PhD Department.
VIA Screen-and-Treat Cervical Cancer Prevention in Guyana: A Mobile Clinic Pilot Project to a Remote Amerindian Community John E. Varallo, MD, MPH, FACOG.
Epidemiology of a Chronic Disease Exercise By Mary Murphy April 2008
Abnormal Pap in Pregnancy Alexander Burnett, MD Division Gyn Oncology, UAMS April, 2006.
SoftPAP® A Novel Collection Device for Cervical Cytology.
Kalavathy Mathur chennath 1, Meera Radhakrishnan 1 Assistant Professor Regional Cancer Centre Trivandrum Kerala, India.
In an effort to further his studies, he went to Germany to study the philosophy of biologic sciences. After a brief period of studying with August.
Screening for cervical cancer. Screening for cervical lesions Common disease Cancer is preventable Screening is easy MUST BE PERFORMED.
Nursing Process HPV.
Health problems and health needs assessment for tailors in Yemetu area of Ibadan, Nigeria, MOTUNRAYO A. FAGBOLA¹, VICTORIA O. OLADOYIN¹ OLUWAKEMI A. SIGBEKU¹,
AGE DIFFERENCE IN CERVICAL NEOPLASIA DISTRIBUTION AMONG WOMEN ATTENDING A HOSPITAL BASED AND PERIPHERAL SCREENING PROGRAMMES Dr.Kalavathy Mathurchennath1,
Cervical Intraepithelial Neoplasm
TEMPLATE DESIGN © Study on Risk Factors for Cervical Carcinoma at Central Women’s Hospital, Yangon Muyar Soe, Myat Thazin.
PREVALENCE OF MDR-TB AMONGST PATIENTS WITH HIV AND TB CO- INFECTION SEEN AT THE DOTS CLINIC OF N.I.M.R., LAGOS, NIGERIA. Enya V.N.V, Onubogu C.C., Wahab.
Factors associated with abnormal PAP Smears in a health center X – Costa Rica, 2009 Leandra Abarca 1, Julia Freer 1, Maricela Salas 2 1, MD, MsC, FETP,
TEMPLATE DESIGN © Negative LLETZ following severe dyskaryosis: a curious phenomenon Üçyiğit A, Jones M H, Dutta A, El.
Proposal by Basic Health International, Inc..  NGO founded by Dr. Miriam Cremer, MD MPH at Mount Sinai School of Medicine, New York City.  Our Vision:
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
Dr Julius Mwaiselage MD PhD Chief, Cancer Prevention and Research Ocean Road Cancer Institute.
Cervical Cancer How We Can Prevent It Dr Quek Swee Chong Himalayan Women’s Health Project 30 August 2014.
Cervical Cancer: Experiences from a Cohort of HIV-infected Women Pascoe M, Magure T, Mudhokwani P et al Abstract: MOAB0202.
The summary of preventive examinations- cervical cancer Agnieszka Wrzesińska, MD Project entitled „ Equal in health – prevention and early detection of.
CERVICAL CANCER PREVENTION STRATEGIES Z Mike Chirenje MD FRCOG Department of Obstetrics and Gynaecology University of Zimbabwe, Harare Zimbabwe
Cytopathology Feb
Morphologic Pap Test Findings in HPV Negative Women Age 30 Years and Older: What Information Will Be Lost with HPV Only Primary Screening? Brooke Henninger,
George Papanikolaou the inventor of test Pap Greek doctor, biologist and researcher Born : 13th May, 1883 Died : 19th February, 1962 (Aged 78)
EBCR Week 2. Case Scenario A woman 31 yo, married, came to GP with recurrent postcoital pervaginal bleeding since 3 weeks ago. Doctor considered that.
Cancer prevention and early detection
Cancer prevention and early detection
Cancer prevention and early detection
Cancer prevention and early detection
University of Rajarata.
MICHAEL OLABODE TOMORI B.PHARM, MSc, MPH
Treatment Options for Cervical Cancer in Low Income Countries
6th International Public Health Conference
Cancer prevention and early detection
Facilitator: pawin puapornpong
Geneva Foundation for Medical Education and Research
Secondhand smoke exposure and cervical cancer:
Hoa Nguyen Lam, Huyen Suong Ho Thi et al.
July 28, 2010 Cervical Dysplasia in Immune Suppressed Women Jill Gaidos Nancy Hardt Faris Hashim.
Knowledge, Attitudes, and Practices Regarding Cervical Cancer and Screening Dr Ghufran Jassim MBBS,MD, MSc, PhD 8/30/2017.
Presentation transcript:

PAP SMEAR FINDINGS AMONG WOMEN SCREENED FOR CERVICAL CANCER AT THE NATIONAL OBSTETRIC FISTULA CENTRE, ABAKALIKI, SOUTH-EAST, NIGERIA BY Dr OKENWA SAMUEL CHIMA

AUTHORS Ekwedigwe K.C, Daniyan ABC, Sunday-Adeoye I, Mbamalu S.O, Okenwa S.C, Iyare F

OUTLINE Introduction Methodology Result Discussion Conclusion Recommendation

ABSTRACT BACKGROUNG: Pap smear also known as Pap test is a procedure used to screen for cervical cancer which is the most common gynaecological cancer in women. OBJECTIVE: The study reviews findings among women screened for cervical cancer at the National Obstetric Fistula Centre with the aim of determining those with the premalignant phase. METHOD: This is a cross sectional retrospective study. The case records of 316 patients who had undergone cervical screening between August 2012 and March 2013 were reviewed for biological, social and cytology findings. Analysis of data was done using SPSS statistics version 21. RESULTS: Majority (33.5%) of patients screened were within ages 30 – 39years, significantly (75.3%) married women presented for screening, most (57.6%) of the patients were civil servants. Vaginal examination did show 87.7%had normal findings and 2.5% had abnormal bleeding. 66.5% were negative on visual inspection by acetic acid and the Pap smear results showed 50% of patients had normal findings and 26.6% had inflammatory cells on cytology. Only 0.6% showed dysplasia on pap smear. CONCLUSION: The study showed a high awareness among married women and majority of women had normal Pap smear findings. KEYWORD: PAP SMEAR, CERVICAL CANCER.

INTRODUCTION Cervical cancer is the most common gynaecological cancer only second to breast cancer in women 1 The incidence of cervical cancer in Nigeria is 250/ per year 2 This condition is largely preventable by effective screening programmes 3 Pap smear is a screening test for cervical cancer The test was invented by and named after a Greek doctor George Papanicolaou in Pap smear is regarded to be very specific but only moderately sensitive 5

METHODOLOGY This study was done at the National Obstetric Fistula Centre, Abakaliki, South-East, Nigeria from August 2012 to March 2013 Study Population: Women who have attained reproductive age status Study Design: A retrospective study Sample size A total of 316 women entered for this study, women who had presented for cervical cancer screening The biological, social and cytological findings of these women screened were documented for the basis of this study

Sampling Technique: Convenient sampling method was used and analysis was done using SPSS vs. 21 Inclusion Criteria: Women who have attained reproductive age and have commenced sexual activities Exclusion Criteria: * Women who are menstruating * Women with obvious cervical lesions Limitation of Study: Visual inspection by Lugol’s iodine was not done

n=316% Age < > Parity > Marital status SINGLE175.4 MARRIED DIVORCED/SEPARATED20.6 WIDOW Occupation FARMING TRADER STUDENT123.8 CIVIL SERVANT NONE113.5 ARTISAN175.4 SOCIODEMOGRAPHIC VARIABLES

VAGINAL EXAMINATION FrequencyPercent NORMAL BLEEDING82.5 LESION206.3 IUCD THREAD2.6 DISCHARGE92.8 Total VIA FrequencyPercent POSITIVE NEGATIVE Total

PAP SMEAR RESULT FrequencyPercent NORMAL FINDINGS INFLAMMATORY UNSACTISFACTORY DYSPLASIA2.6 Total

PAP SMEAR RESULTTotal NORMAL FINDINGSINFLAMMATORYUNSACTISFACTORYDYSPLASIA VIA POSITIVE NEGATIVE Total P>0.05 Relationship Between Pap Smear findings and VIA

RESULT Majority (33.5%) of patients screened were within ages 30 – 39 years, with a mean age of years. Most patients were Para 4 and above Significantly (75.3%) married women presented for screening, of which most (57.6%) were civil servants Vaginal examination did show 87.7% had normal findings and 2.5% had abnormal bleeding On visual inspection by acetic (VIA) acid 66.5% were negative

RESULTS contd Pap smear results showed 50% of patients had normal findings and 26.6% had inflammatory cells Only 0.6% showed dysplasia on pap smear There is no statistical significant difference between Pap smear findings and VIA findings

DISCUSSION From the result, majority were above the age of 30 years, this result is similar to studies FETHA Abakaliki 6 but varies with a study done in Nnewi where majority of the respondents where between ages 25 – 29years 7 Most of the women were married, this is in keeping with similar studies done in South-East Nigeria 7 and North Central Nigeria 8 A significant number of patients screened 87.7% had normal findings on vaginal examination

DISCUSSION contd On visual inspection by acetic acid, majority of the patients screened tested negative, this result is similar to a study done in India 9 but varies with a study done in Khartoum, Sudan 10 Results from pap smear taken from screened patients showed 50% of patients had normal findings and only 0.6% showed dysplasia; this is similar to previous study done in Turkey 10 and India 12 Only 2 (0.6%) of the patients screened showed dysplasia on pap smear and these 2 were VIA negative. However, there is no statistical significance difference between Pap smear finding and VIA findings on cervical screening.

CONCLUSION This study showed a high awareness cervical cancer screening among married women and majority of the women had normal Pap smear finding This study also showed that VIA had sensitivity comparable to Pap Smear

RECOMMENDATION For complete cervical cancer screening; VIA, Visual inspection with Lugol’s iodine(VILI) and Pap Smear Should be employed However, in low resource settings VIA alone can be used as a screening tool

References 1. Mahmood IS. Premalignant and malignant disease of the cervix. Dewhurts Gynaecological Obstetrics. 7 th Ed; 2007; Pisani P, Parkin DM, Bray F, Ferley J. Estimates of the worldwide mortality from 25 cancers in Int J Cancer 1999;83: Maheck et al., 1994; Yaren et al., Palatianos GM, Cintron JR, Narula T. George N. Papanicolaou, MD. Father of modern cytology. A 30-year commemorative. J Fla Med Assoc. 1992;79: Cervical Screening Presentations; For Providers of Medical Practioner Education in Queensland; 20:10: Chinaka CC, Udeajah VN. Awareness of cervical cancer screening among women visisting Federal Teaching Hospital Abakalik, Nigeria. Journal of App Med Sci. 4; 2012: Obafunwa et al., 1999; Apgar et al., 2001; Sharp et al., Oche MO, Kaoje AU, Gana G, Ango JT. Int J of Med and Med Sci; 5(4); 2013; Bhavana S, Anita D, Geeta D, Yeshita P, Hema D. Cervical Cancer Screening by Visual Inspection with Acetic Acid – Interobserver Variability between Nurses and Physicians, Asian Pacific JCancer Prevention. 11;2010; Ahmed I, Vibeke R, Eero P, Arja RA. Cervical cancer risk factor and feasibility of visual inspection with acetic acid screening in sudan 11. Ayten D. Pap screening result for Turkish pregnant women. Asian Pacific J Cancer Prevention. 13(11) 2012; Mandakini MP, Amrish NP, Jigna M. Cervical Pap Smear and its utility in Cancer Screening, to specify the Strategy for Cervical Cancer Control. National J Comm Med. 2011;2;1

THANK YOU.